Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution

被引:115
作者
Melendez, AJ
Carlos-Dias, E
Gosink, M
Allen, JM
Takacs, L
机构
[1] Inst Rech Jouveinal Parke Davis, Dept Mol & Cellular Biol, F-94265 Fresnes, France
[2] Parke Davis & Co, Dept Bioinformat, Ann Arbor, MI 48105 USA
关键词
cloning; human; sphingosine kinase; sphingosine-1-phosphate;
D O I
10.1016/S0378-1119(00)00205-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sphingosine-1-phosphate (SPP), the product of sphingosine kinase, is an important signaling molecule with intra- and extracellular functions. The cDNA for the mouse sphingosine kinase has recently been reported. In this paper we describe the cloning, expression and characterization of the human sphingosine kinase (huSPHK1). Sequence analysis comparison revealed that this kinase is evolutionarily very conserved, having a high degree of homology with the murine enzyme, and presenting several conserved regions with bacteria, yeast, plant, and mammalian proteins. Expressed huSPHK1 cDNA specifically phosphorylates D-erythro-sphingosine and, to a lesser extent, D,L-erythro-dihydrosphingosine, and not at all the 'threo' isoforms of dihydrosphingosine; hydroxy-ceramide or non-hydroxy-ceramide; diacylglycerol (DAG); phosphatidylinositol (PI); phosphatidylinositol-4-phosphate (PIP); or phosphatidylinositol-4,5-bisphosphate (PIP2). huSPHK1 shows typical Michaelis-Menten kinetics (V-max = 56 mu M and K-m = 5 mu M). The kinase is inhibited by D,L-threo-dihydrosphingosine (K-i = 3 mu M), and by N,N-dimethyl-sphingosine (K-i = 5 mu M). Northern blots indicate highest expression in adult lung and spleen, followed by peripheral blood leukocyte, thymus and kidney, respectively. It is also expressed in brain and heart. In addition, database searches with the stSG2854 sequence indicate that huSPHK1 is also expressed in endothelial cells, retinal pigment epithelium, and senescent fibroblasts. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 30 条
  • [1] Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
    Becker, KG
    Simon, RM
    Bailey-Wilson, JE
    Freidlin, B
    Biddison, WE
    McFarland, HF
    Trent, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) : 9979 - 9984
  • [2] BUEHRER BM, 1992, J BIOL CHEM, V267, P3154
  • [3] Choi OH, 1996, NATURE, V380, P634
  • [4] Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
    Cuvillier, O
    Pirianov, G
    Kleuser, B
    Vanek, PG
    Coso, OA
    Gutkind, JS
    Spiegel, S
    [J]. NATURE, 1996, 381 (6585) : 800 - 803
  • [5] DESAI NN, 1992, J BIOL CHEM, V267, P23122
  • [6] Edsall LC, 1997, J NEUROSCI, V17, P6952
  • [7] Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families:: Confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q
    Enlund, F
    Samuelsson, L
    Enerbäck, C
    Inerot, A
    Wahlström, J
    Yhr, M
    Torinsson, Å
    Martinsson, T
    Swanbeck, G
    [J]. HUMAN HEREDITY, 1999, 49 (01) : 2 - 8
  • [8] HIRSCHBERG CB, 1970, J BIOL CHEM, V245, P3084
  • [10] ENZYMATIC PHOSPHORYLATION OF SPHINGANINE
    KEENAN, RW
    HAEGELIN, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 37 (06) : 888 - &